Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 30 ($0.39) and last traded at GBX 30.06 ($0.39), with a volume of 20110 shares traded. The stock had previously closed at GBX 33 ($0.43).
Cambridge Cognition Trading Down 1.1 %
The company has a debt-to-equity ratio of 92.53, a quick ratio of 0.96 and a current ratio of 0.65. The firm has a 50-day moving average of GBX 40.19 and a 200-day moving average of GBX 43.53. The firm has a market capitalization of £11.61 million, a P/E ratio of -725.00 and a beta of 0.72.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Read More
- Five stocks we like better than Cambridge Cognition
- There Are Different Types of Stock To Invest In
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- How to Use the MarketBeat Stock Screener
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What Are Growth Stocks and Investing in Them
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
